Enzyme Drives Treatment Resistance in Ovarian Cancer - News Center
Researchers at Northwestern Medicine identify PRMT5 as a key driver in chemotherapy resistance for advanced ovarian cancer, revealing potential targets for treatment.
Enzyme Drives Treatment Resistance in Ovarian Cancer - News Center
Researchers at Northwestern Medicine identify PRMT5 as a key driver in chemotherapy resistance for advanced ovarian cancer, revealing potential targets for treatment.
